Literature DB >> 4678061

Complete regressions of mycosis fungoides with topical mechlorethamine hydrochloride.

E J Van Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4678061     DOI： 10.1001/jama.222.9.1172b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.

Authors:  Stuart R Lessin; Madeleine Duvic; Joan Guitart; Amit G Pandya; Bruce E Strober; Elise A Olsen; Christopher M Hull; Elizabeth H Knobler; Alain H Rook; Ellen J Kim; Mark F Naylor; David M Adelson; Alexa B Kimball; Gary S Wood; Uma Sundram; Hong Wu; Youn H Kim
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

2.  Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.

Authors:  Carolina V Alexander-Savino; Catherine G Chung; Elaine S Gilmore; Sean M Carroll; Brian Poligone
Journal:  Dermatol Ther (Heidelb)       Date:  2022-02-05

3.  STING expression is an independent prognostic factor in patients with mycosis fungoides.

Authors:  Reiko Takayanagi-Hara; Yu Sawada; Hitomi Sugino; Yoko Minokawa; Hikaru Kawahara-Nanamori; Misa Itamura; Tomoko Tashiro; Ayaka Kaneoka; Natsuko Saito-Sasaki; Kayo Yamamoto; Etsuko Okada
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.